Durgam Suresh K. (CIK 1829958) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-04-02). Recent activity: Sell ITCI (42,913 shares), Buy ITCI (13,133 shares), Sell ITCI (5,572 shares), Buy ITCI (7,345 shares), Sell ITCI (3,116 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-02 | Intra-Cellular Therapies, Inc. (ITCI) | EVP, Chief Medical Officer | Sell | 42,913 | $5.7M |
| 2025-03-10 | Intra-Cellular Therapies, Inc. (ITCI) | EVP, Chief Medical Officer | Buy | 13,133 | $0 |
| 2025-03-10 | Intra-Cellular Therapies, Inc. (ITCI) | EVP, Chief Medical Officer | Sell | 5,572 | $730,991 |
| 2025-03-10 | Intra-Cellular Therapies, Inc. (ITCI) | EVP, Chief Medical Officer | Buy | 7,345 | $0 |
| 2025-03-10 | Intra-Cellular Therapies, Inc. (ITCI) | EVP, Chief Medical Officer | Sell | 3,116 | $408,944 |
| 2025-03-04 | Intra-Cellular Therapies, Inc. (ITCI) | EVP, Chief Medical Officer | Buy | 8,742 | $0 |
| 2025-03-04 | Intra-Cellular Therapies, Inc. (ITCI) | EVP, Chief Medical Officer | Sell | 3,709 | $475,494 |
| 2025-02-04 | Intra-Cellular Therapies, Inc. (ITCI) | EVP, Chief Medical Officer | Buy | 11,017 | $0 |
| 2025-02-04 | Intra-Cellular Therapies, Inc. (ITCI) | EVP, Chief Medical Officer | Sell | 4,730 | $600,710 |
Source: SEC Form 4 filings · as of 2025-04-02